Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease

被引:43
|
作者
Combarros, O [1 ]
García-Román, M
Fontalba, A
Fernández-Luna, JL
Llorca, J
Infante, J
Berciano, J
机构
[1] Univ Cantabria, Univ Hosp Marques De valdecilla, Neurol Unit, E-39008 Santander, Spain
[2] Univ Cantabria, Univ Hosp Marques De valdecilla, Mol Genet Unit, E-39008 Santander, Spain
[3] Univ Cantabria, Sch Med, Div Prevent Med, E-39005 Santander, Spain
关键词
Alzheimer's disease; apolipoprotein E; H63D mutation; hemochromatosis; HFE gene;
D O I
10.1159/000068480
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The H63D mutation in the hemochromatosis gene (HFE) has recently been considered as a risk factor in Alzheimer's disease (AD) with advancing age at onset of the disease, independently of the apolipoprotein E (ApoE) epsilon4 allele effect. We examined the distribution of the H63D mutation and ApoE genotypes as a function of age at AD onset in 328 patients with sporadic AD. Our data show that the mutant H63D allele potentially interacts with the ApoE F,4 allele to significantly reduce age at onset of AD compared to ApoE epsilon4 carriers alone, but has no effect on age at onset in ApoE epsilon4 non-carriers. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:151 / 154
页数:4
相关论文
共 50 条
  • [21] The apolipoprotein E ε4 allele and the response to tacrine therapy in Alzheimer's disease
    Rigaud, AS
    Traykov, L
    Caputo, L
    Guelfi, MC
    Latour, F
    Couderc, R
    Moulin, F
    de Rotrou, J
    Forette, F
    Boller, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (03) : 255 - 258
  • [22] A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease
    Steffens, DC
    Plassman, BL
    Helms, MJ
    WelshBohmer, KA
    Saunders, AM
    Breitner, JCS
    BIOLOGICAL PSYCHIATRY, 1997, 41 (08) : 851 - 856
  • [23] Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease
    Arai, H
    Terajima, M
    Nakagawa, T
    Higuchi, S
    Mochizuki, H
    Sasaki, H
    NEUROREPORT, 1996, 7 (04) : 918 - 920
  • [24] Apolipoprotein E epsilon 4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease
    Algotsson, A
    Nordberg, A
    Lannfelt, L
    Almkvist, O
    Winblad, B
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1996, 22 (03) : 223 - 232
  • [25] The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease
    Landen, M
    Thorsell, A
    Wallin, A
    Blennow, K
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (04) : 352 - 356
  • [26] The apolipoprotein E epsilon 4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
    Minthon, L
    Hesse, C
    Sjogren, M
    Englund, E
    Gustafson, L
    Blennow, K
    NEUROSCIENCE LETTERS, 1997, 226 (01) : 65 - 67
  • [27] Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease
    Basso, Michael
    Gelernter, Joel
    Yang, John
    MacAvoy, Martha G.
    Varma, Pradeep
    Bronen, Richard A.
    van Dyck, Christopher H.
    NEUROBIOLOGY OF AGING, 2006, 27 (10) : 1416 - 1424
  • [28] The allele interaction between apolipoprotein ε2 and ε4 in Taiwanese Alzheimer's disease patients
    Lung, FW
    Yen, YC
    Chou, LJ
    Hong, CJ
    Wu, CK
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (01) : 38 - 43
  • [29] Apolipoprotein E ε4 allele differentiates the clinical response to donepezil in Alzheimer's disease
    Bizzarro, A
    Marra, C
    Acciarri, A
    Valenza, A
    Tiziano, FD
    Brahe, C
    Masullo, C
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (04) : 254 - 261
  • [30] Apolipoprotein E ε4 allele increases risk for psychotic symptoms in Alzheimer's disease
    Zdanys, Kristina F.
    Kleiman, Timothy G.
    MacAvoy, Martha G.
    Black, Benjamin T.
    Rightmer, Tracy E.
    Grey, Monique
    Garman, Katherine S.
    Tampi, Rajesh R.
    Gelernter, Joel
    van Dyck, Christopher H.
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (01) : 171 - 179